Vyleesi (bremelanotide) is a prescription medication used to treat acquired, generalized hypoactive sexual desire disorder (HSDD) in women who have not yet gone through menopause. It is designed for women experiencing a sudden, persistent drop in sex drive that causes personal distress, and is not caused by relationship issues, health problems, or other medications.
- How it works: It acts as a melanocortin receptor agonist. While the exact mechanism is not fully understood, it is believed to activate receptors in the central nervous system to help regulate mood and desire.
- How it is taken: It is an on-demand, self-administered subcutaneous injection. You inject it into the abdomen or thigh at least 45 minutes before anticipated sexual activity.
- Strict dosing limits: You must never take more than 1 dose within a 24-hour period and no more than 8 doses within a single month
-
- Common side effects: Nausea is the most common effect, impacting roughly 40% of users, though it often improves after the first few doses. Flushing (hot flashes), headaches, and injection site reactions are also common.
- Blood pressure changes: Vyleesi can cause a temporary increase in blood pressure and a decrease in heart rate, which typically resolves within 12 hours. Because of this, it is not recommended for individuals with uncontrolled high blood pressure or known heart disease.
- Skin darkening: Focal hyperpigmentation (darkening of the skin on the face, gums, or breasts) can occur, especially in individuals with darker skin tones or with frequent use.





Reviews
There are no reviews yet.